Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Culturable-mitochondrial-cells-with-no-nucleus-showing-mitochondrial-activity

 Continuous process for ethanol production by bacterial fermentation
The accompanying FIGURE will provide a background for the following discussion in which the method ...


 Stable solution of hyaluronate in a balanced salt medium
What is claimed is: 1. A physiological visco-elastic formulation consisting of sodium hyaluronate ...


 Radiolabeled fusion toxins for cancer therapy
The present invention describes the synthesis and purification of a new class of compounds known as ...


 Genetically modified cells expressing a TGF.beta. inhibitor, the cells being lung cancer cells
OF THE PREFERRED EMBODIMENT Lung cancers account for 30% of all death due to cancer in the United S...


 Auto-ligating oligonucleotide compounds
OF THE INVENTION The invention relates to a method and compositions for in situ formation of an ...


 Nucleic acids encoding transcription factor APRF (acute phase response factor)
What is claimed: 1. An isolated DNA molecule which encodes a human APRF polypeptide having the ...


 Antisense modulation of stat3 expression
OF THE INVENTION STAT3 plays an important role in cytokine signal transduction. Overexpression and/...


 Cold-active beta-galactosidase, the process for its preparation and the use thereof
The object of the present invention is to hydrolyse lactose by using a .beta.-galactosidase, which ...


 Method of delivering powder transdermally with needless injector
What we claim is: 1. A method of therapeutic treatment, comprising transdermally delivering ...


 Telomere repeat binding factors and diagnostic and therapeutic use thereof
The present invention provides vertebrate telomeric binding factors (TRFs) that bind to the TTAGGG ...


 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity

Details
Inventors: Nakano, Kazutoshi; Ohta, Shigeo;
Assignee: Eisai Research Institute (Tokyo, JP)
Primary Examiner: Qian; Celian
Assistant Examiner: Dunston; Jennifer
Attorney, Agent or Firm: Choate, Hall & Stewart, LLP

Provided are a method of producing a culturable cell with no nucleus, showing mitochondrial activity, comprising: performing cell fusion between a nucleus-less cell having mitochondrial DNA and a mitochondrial DNA-less cultured cell derived from a cancer cell; culturing resulting cybrid cells; and recovering floating cells from obtained cultured cells, and a cell obtained by the method.

DETAILED DESCRIPTION OF THE INVENTION Hereinafter, the present invention will be described in detail.
(1) Method of Producing the Cells of the Present Invention The present invention relates to a method of producing a culturable cell with no nucleus, showing mitochondrial activity, comprising: performing cell fusion between a nucleus-less cell having mitochondrial DNA and a mitochondrial DNA-less cultured cell derived from a cancer cell; culturing resulting cybrid cells; and recovering floating cells from obtained cultured cells.
Hereinafter, a culturable cell with no nucleus, showing mitochondrial activity is also referred to as a "mitochondrial cell.
" The nucleus-less cell having mitochondrial DNA used in the method of the present invention may be a cell that is produced by enucleating a cell that has a nucleus and mitochondrial DNA or a cell that genetically lacks a nucleus but has mitochondrial DNA.
It is preferred that the cell that genetically lacks a nucleus but has mitochondrial DNA be used.
Examples of such a cell include platelets.
The cell that lacks a nucleus but has mitochondrial DNA can be obtained from an organism that has mitochondrial DNA in the cell.
As such an organism, mammals are preferred with human being particularly preferred.
In the method of the present invention, use of cells obtained from patients with mitochondria-associated diseases from whom informed consents were obtained in advance as the cells that lack a nucleus but have mitochondrial DNA can provide mitochondrial cells each having a mutation of mitochondrial disease.
Examples of mitochondria-associated diseases include mitochondrial diseases such as Leigh syndrome, Alzheimer's disease and Parkinson's disease.
The mtDNA-less cultured cells derived from cancer cells that are used in the method of the present invention include known Rho.
sup.
0 cell lines that have a nucleus but no mtDNA.
Specific examples thereof include Hela Rho.
sup.
0 cell line, fibroblast Rho.
sup.
0 cell line, and osteosarcoma Rho.
sup.
0 cell line



Related patents
  Antisense oligonucleotides inhibiting human bcl-2 gene expression
The invention provides oligodeoxynucleotides and methods for inhibiting growth of lymphoma or leukemia cells, that are types of lymphocytes. An antisense ...
  Process for the synthesis of oligomeric compounds
What is claimed is: 1. A method for the preparation of an oligomeric compound having a moiety of Formula I: ##STR38## wherein: X.sub.4 is Z or H; Z is CN, halogen, ...
  Process for oligonucleotide synthesis
OF THE PREFERRED EMBODIMENTS The present invention is directed to methods for linking a phosphoramidite nucleoside to a solid support-bound nucleoside. These methods ...
  Derivatized oligonucleotides having improved uptake and other properties
OF THE INVENTION Antisense therapeutics can be practiced in a variety of organisms ranging from unicellular prokaryotic and eukaryotic organisms to multicellular ...
  Process for the synthesis of oligomeric compounds
What is claimed is: 1. A compound having the formula: ##STR38## wherein: X.sub.4 is Z or H; Z is CN, a halogen radical, , alkaryl, substituted sulfoxyl, substituted ...
  Processes for the synthesis of oligomeric compounds
OF PREFERRED EMBODIMENTS The present invention provides methods for the preparation of oligomeric compounds having at least one phosphodiester or phosphorothioate ...
  Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
OF THE INVENTION Usually, in the method of synthesis of the radiolabelled platinum chemotherapeutic agent the step of converting the metal halide into a radiolabelled ...
  Pharmaceutical composition for diabetic neuropathy
What is claimed is: 1. A method for the prophylaxis of diabetic peripheral neuropathy, which comprises administering an effective amount of cytidine 5'-diphosphocholine ...
  Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
This invention aids in fulfilling this need in the art by providing an in vitro, single cycle, recombinant virus assay (RVA) for determining inhibition of HIV ...
  Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance
OF THE INVENTION The present invention relates to new and useful methods including methods for detecting HIV, methods for detecting HIV drug resistance, methods for ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved